Background: Malaria and acute bacterial meningitis (ABM) are the leading infectious causes of febrile encephalopathy in malaria endemic settings. The clinical distinction of the two conditions is complicated by overlap in clinical features. Objective: To determine the clinical predictors for malaria, ABM and treatment outcome in febrile children aged 2 months to 12 years with altered mentation at two tertiary hospitals in Northwestern Tanzania. Methods: Prospective study of 103 children to document demographic data and physical examination findings, such as level of consciousness and meningeal irritations. Laboratory results for cerebrospinal fluid, hemoglobin, malaria and HIV were also evaluated. Results: Age >60 months and hemoglobin 5 g/dl were independent predictors of malaria; (p ¼ 0.013 and 0.004, respectively). HIV infection was the only predictor of meningitis, p ¼ 0.037, and mortality was high if the diagnosis was unconfirmed. Conclusions: Children with febrile encephalopathy are more likely to have malaria than ABM if they have severe anemia.
the family and to the already overstretched health systems [3, 4] . The challenge to clinicians in these settings is therefore to distinguish malaria from ABM in febrile child presenting with AMS at first presentation to institute accurate and timely treatment [5] . In these settings with limited laboratory capacity, clinicians use the WHO-Integrated Management of Childhood Illnesses (IMCI) strategy, which recommends a symptomatic approach in diagnosing common childhood illnesses in limited resource settings and administer timely treatment [6] . The usefulness of this approach for diagnosing malaria and meningitis in febrile children presenting with neurological symptoms is challenged by the similarities in clinical presentations, and studies in malaria endemic regions to investigate independent clinical predictors have been inconsistent and require further evaluation [7] . This study was conducted to determine clinical and basic laboratory features, which can be used to distinguish malaria from ABM in febrile children with altered mentation and predictors of in hospital mortality among children admitted at a tertiary hospital in northwestern Tanzania.
M A T E R I A L A N D M E T H O D S
This was a prospective study conducted at two referral hospitals (Bugando Medical Centre and SekouToure regional hospital) in Mwanza, northwestern Tanzania, involving children aged 2 months to 12 years from November 2011 to April 2012.
Children with fever (or history of fever before admission) defined as axillary temperature 38 C) and AMS defined as Blantyre Coma Score (BCS) 4 in children aged <4 years or Glasgow Coma Score (GCS) 14 in children aged 4-12 years were enrolled in our study. Parents or guardians were interviewed for demographic details and symptoms using a standardized questionnaire. Physical examination was performed to look for features of malaria and meningitis, such as level of consciousness, palor, jaundice or organomegally and signs of meningeal irritation. Laboratory investigations performed included random blood glucose, peripheral blood smear for malaria parasites and rapid test for malaria, complete blood count, blood culture and lumbar puncture for cerebrospinal fluid (CSF) analysis. The CSF was analyzed for macroscopic appearance, sugar, protein level, total cell count and differential and Gram stain. A portion of CSF (3 ml) was sent for latex agglutination tests, culture and sensitivity pattern. For the HIV-infected children, CSF Indian ink stain was performed for cryptococcal meningitis. CSF Latex agglutination test was performed using the Pastorex TM Meningitis latex agglutination test kit for detection of soluble antigen and identification of Neisseria meningitidis A, C, Y, W135, B/K1 Escherichia coli, Hemophillus influenzae Type B (Hib), Streptococcus pneumoniae and Group B Streptococcus (Alere San Diego, Inc. San Diego, California. USA). CSF culture was done after a centrifuged portion of CSF specimen was inoculated on chocolate agar plate and incubated in air plus 5-10% carbon dioxide. Blood cultures were done by inoculation of blood collected in a sterile culture bottle with broth media on sheep blood agar and incubated on air plus 5-10% CO 2 at 35 C. Thick blood smear for malaria parasites was Giemsa stained, and malaria rapid diagnostic test (MRDT) was done using SD Bioline Malaria Rapid tests (Standard Diagnostics INC, Kyonggi-Do, Korea), HIV tests were done using the SD Bioline HIV rapid tests (Standard Diagnostics INC, Kyonggi-Do, Korea) and complete blood count was performed using an automated machine Cell dyn 3700 (Abbott Diagnostics, Wiesbaden, German).
Malaria was defined by WHO definition as the presence or history of fever before admission accompanied by a positive test for malaria (blood smear or rapid test or both) [8] . ABM was defined by WHO case definition as follows: suspected ABM: presence of fever (>38.0 C axillary) and one of the following signs: altered consciousness or signs of meningeal irritation; probable ABM: CSF examination showing at least one of the following: turbidity, leukocytosis (>100 cells/mm 3 ), leukocytosis (10-100 cells/ mm 3 ) and either or an elevated protein (>100 mg/ dl) or decreased glucose (<40 mg/dl); confirmed ABM was defined as laboratory-confirmed by bacterial growth or identifying (by Gram stain or antigen detection) of bacterial pathogen in the CSF or blood in a child with a clinical syndrome consistent with ABM [9] . Malaria and bacterial meningitis were managed using National and WHO recommended guidelines for management of severe malaria and ABM, respectively, with intravenous quinine at 10 mg/kg three times per day until the patient could take oral artemether lumfantriene for malaria and 100 mg/kg intravenous cefrtriaxone per day for 7-10 times depending on clinical response [10, 11] . Antibiotics were stopped if malaria test was positive and the patient clinically improved. Other supportive treatments included maintenance fluids, blood transfusion, fever medication and anticonvulsants. Patients were reviewed daily to monitor progress, including vital signs, level of consciousness, inputs and outputs, and at discharge treatment, outcome was documented.
Data were analyzed using STATA version 10 (College Station, Texas, USA). Variables were analyzed as proportions for categorical variables and means for continuous variables. Median was used for variables not normally distributed. Multivariate analysis was performed, and odds ratio (OR) and corresponding 95% confidence intervals (CIs) used to predict malaria and/or ABM. Pearson's chisquare test was used to analyze the differences between different clinical groups. Variables were taken for multivariate analysis if the p-value was 0.1. Observations were considered significant for p-values <0.05.
Ethical approval was granted by institutional publication and ethical committee, and permission to conduct the study sought from respective hospitals. The study procedures were explained to the patients' caretakers before recruitment into the study followed by a signed consent by a guardian.
R E S U L T S
Baseline characteristics of study patients One hundred and three (103) patients were enrolled in six months as shown in Figure 1 . In total, 54 percent of the patients 54.4% (56 of 103) were males with a median age of 34.5 months [interquartile range: 2-120]. Nineteen patients (18.4%) had severe AMS. Majority of children had received pretreatment with either antimalarial or antibiotics from referring health facility. Thirty-nine patients 37.8% (39 of 103) were confirmed to have malaria parasites; 25 patients by peripheral smear, 10 by MRDT and blood smear positive and 4 by MRDT alone. All CSF cultures were negative for bacteria pathogens, and one patient had a positive latex agglutination test for S. pneumoniae. Using the WHO case definition for ABM, nine (9 of 103) patients had CSF alteration consistent with probable ABM and three patients had positive blood culture (two Klebsiella pneumoniae and one E. coli). In total, Of 12 patients (12 of 103) with HIV infection, 3 had positive Indian ink stain for cryptococcal meningitis. Three children had malaria and meningitis coinfection. In more than half (52 of 103) of children, no pathogen was identified from the laboratory tests performed. (Other baseline characteristics of enrolled patients are summarized in Table 1 ). Table 4 .
D I S C U S S I O N
In malaria endemic regions, overlap in clinical features between malaria and ABM compounded by limited diagnostic capacity poses a diagnostic challenge to clinicians to distinguish the two [12] . High mortality is reported in a group of patients with no pathogen identified. In this study, we aimed to identify clinical features, basic laboratory findings to be used by clinicians in a limited resource settings to distinguish malaria from ABM and predict patients at high risk of poor treatment outcome.
Despite the progressive decline in malaria transmission recently observed in most malaria endemic regions, malaria remains to be the commonest cause of fever with neurological involvement. In our study, 37.8% (39 of 103) patients were confirmed to have malaria in line with studies reported from other neighboring countries such as Uganda and Malawi [13] . Using the WHO case definition for ABM, nine patients had probable meningitis, one patient had a positive latex agglutination test for S. pneumoniae, while three patients had positive blood culture positive with a clinical syndrome consistent with ABM making a prevalence of 12.6% (13 of 103) for ABM [6] . Three HIV-infected patients (3 of 12) all in WHO clinical Stage IV had a positive Indian ink stain for cryptococcal meningitis. The prevalence for ABM is probably an underestimate, as 39.8% (41 of 103) of the patients had started antibiotic therapy before lumber puncture. This proportion of ABM was lower compared with rates reported from Zimbabwe, and Papua New Guinea of 15% can partly be attributed to the impact of Hib vaccination introduced 3 years before our study [13, 14] . In line with our findings, other from developing countries have reported high morbidity and mortality in the group of patients with no organism identified emphasizing the need to broaden the diagnostic work up in this group to identify other causes of febrile encephalopathy, such as viral encephalitis and tuberculous meningitis [15, 16] .
Predictors of malaria Age >60 months, short fever duration and severe anemia Hb < 5 g/dl were associated with malaria in line with studies in Gabon and Ghana among febrile children with falciparum malaria reporting anemia to predict malaria in 67.8 and 55% of children, respectively [17, 18] . Severe anemia is seen mostly in infants because of poor partial immunity acquired among adults leading to high parasitaemia and massive hemolysis, but in view of the wide CIs in our data, there still remains a risk of falciparum malaria coexisting with bacterial infection even in anemic patients [19] . Repeated seizures and severe AMS (GCS < 8 and BCS < 2) were seen in older children (>60 months) and independently predicted malaria an observation reported in other studies attributing this to the interaction between partially acquired immunity against plasmodium falciparum from repeated infection during early childhood [20] . The occurrence of malaria with neurological symptoms in older children seen in our study perhaps highlights declining malaria transmission leading to delay in acquiring immunity to falciparum malaria [21] .
Predictors of ABM High fever >38.5 C, fever >7 days and HIV infection were significant predictors of ABM. HIV infection was the only independent predictor for ABM, OR 3.7, 95% CI (1.2-167.6), p ¼ 0.037.This finding, as expected in advanced HIV infection, was reported in Malawi in 2003 in which HIV-infected children had higher risk of severe disease at presentation [22] . Predictors of in-hospital mortality In total, 6 of 103 patients died in a group with no pathogen identified; this high mortality might be because of misdiagnosis and inappropriate therapy. Similar rates of high mortality in this group of patients were reported in other studies underscoring the need to expand the diagnostic investigations and aggressive treatment during hospital admission [18, 23] . HIV status, multiple seizures and severe AMS (GCS 8, BCS 2) were predictors of poor in-hospital outcome in line with a Bangladesh study in which prolonged fever before admission, level of consciousness and convulsion frequency significantly predicted poor outcome for meningitis [24] . In line with our findings, severe AMS (GCS 8) was reported to be a predictor of mortality in children with nontraumatic coma in Nigeria [1] .
Some limitations for our study include a high number of pretreated patients with antimalarial and antibiotics, which might have underestimated malaria and ABM and lack of diagnostic work up for other causes of febrile encephalopathy. Also, using Indian ink stain for cryptococcal meningitis in HIV-positive children may have reduced the true prevalence compared with cryptococcal antigen test.
In conclusion, at present, further comprehensive well-designed studies with rigorous investigations should be conducted before our evidence can be used to effect therapy. However, febrile children with severe AMS and severe anemia are more likely to have malaria than ABM, and a significant proportion of these children remain at high risk for mortality especially if diagnostic work up is not broadened to look for causes other than malaria and ABM.
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